Try our mobile app

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com


  • Bad financial results growth rate -4.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (12.1%)
  • Dividend yield for the last twelve months 1.8%
  • Free cash flow yield -1.0% (LTM)
  • Share price is 29.8% higher than minimum and 17.3% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (22.5x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $16.5 mln (-0.008% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (+0.6%)117.05
year average price 106.94  


year start price 101.00 2023-09-18

min close price 90.19 2023-10-12

max close price 120.96 2024-03-08

current price 116.40 2024-09-16
Common stocks: 1 746 881 140

Dividend Yield:  1.8%
FCF Yield LTM: -1.0%
EV / LTM EBITDA: 22.5x
EV / EBITDA annualized: 21.8x
Last revenue growth (y/y):  -2.6%
Last growth of EBITDA (y/y):  -7.0%
Historical revenue growth:  +9.1%
Historical growth of EBITDA:  +15.2%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 204 472
Net Debt ($m): 8 677
EV (Enterprise Value): 213 149
EBITDA LTM ($m): 9 481
EV / LTM EBITDA: 22.5x
Price to Book: 5.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-09-16zacks.com

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

2024-09-16fool.com

Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?

2024-09-13seekingalpha.com

Abbott's Still Crushing It

2024-09-13fool.com

3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold

2024-09-10zacks.com

Why Abbott (ABT) Outpaced the Stock Market Today

2024-09-06zacks.com

Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain?

2024-09-05zacks.com

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

2024-09-05zacks.com

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

2024-09-05prnewswire.com

Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.

2024-09-05zacks.com

Should You Continue to Retain ABT Stock in Your Portfolio Now?
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data